News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Genocea Biosciences Release: Novel T Cell Antigen Discovery Platform Providing New Momentum on Malaria Vaccine



4/11/2012 10:20:51 AM

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genocea Biosciences today announced that it will highlight new progress it is making toward the development of an effective vaccine for malaria during a presentation today at the World Vaccine Congress by Jessica Baker Flechtner, Ph.D., Vice President of Research. Dr. Flechtner’s presentation will showcase the company’s novel approach to discovering vaccine candidates derived from antigens that stimulate the T cell arm of the immune system.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES